Hostname: page-component-7b7567c8c-tnkh4 Total loading time: 0 Render date: 2026-11-19T01:35:06.218Z Has data issue: false hasContentIssue false

Assessing the quality of antimicrobial prescribing in solid organ transplant recipients: a new frontier in antimicrobial stewardship

Published online by Cambridge University Press:  03 May 2024

Sagar Kothari
Affiliation:
Transplant Infectious Diseases, Ajmera Transplant Center, University Health Network, Toronto, ON, CanadaTemerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada
Syed Z. Ahmad
Affiliation:
Transplant Infectious Diseases, Ajmera Transplant Center, University Health Network, Toronto, ON, CanadaTemerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada
Michelle T. Zhao
Affiliation:
Transplant Infectious Diseases, Ajmera Transplant Center, University Health Network, Toronto, ON, CanadaTemerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada
Abbigayle Teixeira-Barreira
Affiliation:
Transplant Infectious Diseases, Ajmera Transplant Center, University Health Network, Toronto, ON, Canada
Miranda So
Affiliation:
Sinai Health System-University Health Network Antimicrobial Stewardship Program, University Health Network, Toronto, ON, CanadaLeslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, CanadaDivision of Infectious Diseases, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, VIC, Australia
Shahid Husain*
Affiliation:
Transplant Infectious Diseases, Ajmera Transplant Center, University Health Network, Toronto, ON, CanadaTemerty Faculty of Medicine, University of Toronto, Toronto, ON, CanadaSinai Health System-University Health Network Antimicrobial Stewardship Program, University Health Network, Toronto, ON, Canada
*
Corresponding author: Shahid Husain; Email: shahid.husain@uhn.ca

Abstract

Background:

Post-transplant infections remain a leading cause of morbidity and mortality in solid organ transplant recipients (SOTRs) and local standardized antimicrobial treatment guidelines may contribute to improved clinical outcomes. Our study assessed the rate of therapeutic compliance with local standard guidelines in the treatment of common infections in SOTR, and their associated outcomes.

Methods:

Consecutive adult SOTRs admitted to the transplant floor from January–September 2020 and were treated for an infectious syndrome were followed until discharge or for 30 days following the date of diagnosis, whichever was shorter. Data was extracted from electronic medical records. Guideline compliance was characterized as either appropriate, effective but unnecessary, undertreatment, or inappropriate.

Results:

Nine hundred and thirty-six SOTR were admitted to the transplant ward, of which 328 patients (35%) received treatment for infectious syndromes. Guidelines were applicable to 252 patients, constituting 275 syndromes: 86 pneumonias; 82 urinary tract infections; 40 intra-abdominal infections; 38 bloodstream infections; and 29 C. difficile infections. 200/246 (81%) of infectious syndromes received appropriate or effective but unnecessary empiric treatment. In addition, appropriate tailoring of antimicrobials resulted in a significant difference in 30-day all-cause mortality (adjusted OR of 0.07, 95% CI 0.01–0.38; P = .002). Lastly, we found that guideline-compliant empiric therapy was found to prevent the development of multi-drug resistance in a time-dependent analysis (adjusted HR of 0.21, 95% CI 0.08–0.52; P = .001).

Conclusion:

Our data show that adherence to locally developed guidelines was associated with reduced mortality and resistant-organism development in our cohort of SOTR.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Figure 1.Study Flow Diagram.

Figure 1

Table 1.Cohort Demographics at Baseline

Figure 2

Table 2.Prevalence of guideline-compliant empirical prescribing by clinical syndrome

Figure 3

Table 3.Prevalence of outcome events by empirical guideline concordance category

Figure 4

Table 4.Multivariable Regression of Outcomes, by Compliance with Empiric Therapy (Compliant vs reference)

Figure 5

Table 5.Multivariable Regression of Outcomes, by Compliance with Tailored Therapy (Compliant vs reference)

Figure 6

Figure 2.Kaplan-Meier estimates of guideline compliant versus non-compliant empiric therapy on development of resistance.

Supplementary material: File

Kothari et al. supplementary material

Kothari et al. supplementary material
Download Kothari et al. supplementary material(File)
File 22 KB